Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Adding nitrate to everyday oat-based foods to boost nitric oxide and support blood vessel health.

Official title: An Open-Label, Randomised, Crossover Study to Investigate the Feasibility of Nitrate Fortification in Commonly Consumed Foods for Regulating Nitric Oxide Metabolism in Healthy Individuals

Run by Queen Mary University of London · NCT07172425 · Data updated 2026-11-12

We will test whether adding inorganic nitrate to oat-based foods boosts nitric oxide levels and lowers blood pressure in healthy adults aged 18–60.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment30 (estimated)
SponsorQueen Mary University of London
Academic / other
Locations1 site (London)
StatusRecruiting
StartedOctober 15, 2025
Main results expectedMay 15, 2026
Study endsFebruary 2027
Registry record updatedJune 4, 2026
Trial IDNCT07172425 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are healthy adults aged 18–60 who can give informed consent, are not pregnant, are not taking chronic medications, and have no history of hypertension, diabetes, or major cardiovascular disease.

Probably not a fit

People with existing hypertension, diabetes, other chronic illnesses, pregnancy, or those taking chronic medications are unlikely to benefit from this healthy-volunteer test and are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This open-label, randomized crossover study will recruit 30 healthy adults (15 men, 15 women) to receive three different potassium nitrate–fortified oat-based foods (biscuits, porridge, cereal bar) across separate visits. Participants will attend seven clinic visits for serial blood pressure measurements and collection of blood, urine, and saliva samples up to 24 hours after each supplement to measure nitrate, nitrite, and vascular responses. Each participant acts as their own control by receiving all three fortified products in random order. The primary focus is short-term changes in nitric oxide bioavailability and clinic blood pressure following single consumption of each fortified food.

Why it matters

Potential benefit: If successful, this approach could provide a low-cost, widely acceptable way to increase nitric oxide intake and help reduce population blood-pressure risk.

How similar studies have gone: Previous work using beetroot juice or potassium nitrate capsules has shown short-term blood-pressure lowering and improved endothelial function, though food fortification is a newer, less-studied delivery approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Healthy volunteer.
2. Aged ≥18 years and ≤ 60 years.
3. Willing to provide informed consent.
4. Able to understand and comply with protocol requirements, instructions, and stated restrictions.

Exclusion Criteria:

A volunteer will not be eligible for inclusion in this study if any of the following criteria are met:

1. Unwilling to provide consent.
2. People with chronic health conditions requiring medication.
3. Pregnant females, or those with a possibility of being pregnant.
4. History of hypertension and /or diabetes.
5. History of any serious illnesses, including recent infections or trauma.
6. History of symptomatic coronary artery disease, stroke, or other known atherosclerotic diseases.
7. People who will commence or who are likely to commence treatment with non-steroidal anti-inflammatory drugs (NSAIDs) other than aspirin, from screening until study completion.
8. Self-declared alcohol or drug abuse within the past 6 months.
9. Three-month prior history of regular alcohol consumption exceeding an average weekly intake of \> 28 units (or an average daily intake of greater than 3 units) for males, or an average weekly intake of \> 21 units (or an average daily intake of greater than 2 units) for females. One unit is equivalent to a half pint (284mL) of beer/lager; 25mL of spirits, or 125mL of wine.
10. Taking systemic medication (other than the oral contraceptive pill).
11. Recent (within 2 weeks) self-reported use of mouthwash or tongue scrapers.
12. Recent (within 2 weeks) or current antibiotic use.
13. Recent (within 1 week) use of NO3- or NO2- supplements.
14. History, or recent treatment of (within the last 3 months) for any oral condition (excluding caries), including gingivitis, periodontitis and halitosis.
15. History of, or recent treatment for, any blood-borne infectious disease such Hepatitis B or C virus, or HIV.
16. Current smokers (including vaping) or have smoked within the last 6 months.
17. Diagnosis of rheumatoid arthritis, connective tissue disorders, and other conditions known to be associated with chronic inflammation (e.g., Inflammatory Bowel Disease).
18. People who have donated more than 500mL of blood within 56 days prior to the study commencement.
19. Known allergy to celery, gluten, crustaceans, eggs, lupin, milk, mustard, peanuts, sesame, soybeans, tree nuts, oats, palm oil, sugar, cranberries, sunflower oil, invert syrup, sodium bicarbonate.

Where it's running

  • The William Harvey Research Institute, Centre for Cardiovascular Medicines and Devices, Queen Mary University of London
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.